Cite
Chyla B, Daver N, Doyle K, et al. Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. Am J Hematol. 2018;doi: 10.1002/ajh.25146.
Chyla, B., Daver, N., Doyle, K., McKeegan, E., Huang, X., Ruvolo, V., Wang, Z., Chen, K., Souers, A., Leverson, J., Potluri, J., Boghaert, E., Bhathena, A., Konopleva, M., & Popovic, R. (2018). Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. American journal of hematology, . https://doi.org/10.1002/ajh.25146
Chyla, Brenda, et al. "Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia." American journal of hematology vol. (2018). doi: https://doi.org/10.1002/ajh.25146
Chyla B, Daver N, Doyle K, McKeegan E, Huang X, Ruvolo V, Wang Z, Chen K, Souers A, Leverson J, Potluri J, Boghaert E, Bhathena A, Konopleva M, Popovic R. Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. Am J Hematol. 2018 May 17; doi: 10.1002/ajh.25146. Epub 2018 May 17. PMID: 29770480; PMCID: PMC6120451.
Copy
Download .nbib